Home » Stocks » SNN

Smith & Nephew PLC (SNN)

Stock Price: $43.25 USD 0.14 (0.32%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
Market Cap 19.22B
Revenue (ttm) 4.56B
Net Income (ttm) 448.00M
Shares Out 439.55M
EPS (ttm) 1.02
PE Ratio 42.24
Forward PE 22.78
Dividend $0.38
Dividend Yield 0.87%
Trading Day June 22
Last Price $43.25
Previous Close $43.11
Change ($) 0.14
Change (%) 0.32%
Day's Open 43.12
Day's Range 42.92 - 43.37
Day's Volume 289,666
52-Week Range 33.88 - 45.54

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

LONDON, May 5, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of ARIA Home PT, a remote physical therapy product as part of the ...

1 month ago - PRNewsWire

LONDON, April 30, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of th...

1 month ago - PRNewsWire

Smith & Nephew PLC (LON:SN.) reinstated full-year guidance as visibility is improving thanks to the COVID-19 vaccine rollout programmes and healthcare systems reopening to non-urgent surgery.

1 month ago - Proactive Investors

LONDON, April 28, 2021 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces a new study showing that computer-guided technology for total hip arthro...

1 month ago - PRNewsWire

LONDON, April 20, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces new enabling technologies for its INTELLIO™ Connected Tower Solution with ...

2 months ago - PRNewsWire

LONDON, April 13, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce that its wireless, wearable LEAF Patient Monitoring System has  mon...

2 months ago - PRNewsWire

LONDON, March 25, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a marketing collaboration with Movendo Technology (Genoa, Italy) that will...

2 months ago - PRNewsWire

LONDON, March 18, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a real-world study from Spain that showed how a swit...

3 months ago - PRNewsWire

Medical device maker Smith & Nephew plc (NYSE: SNN) slips in the premarket after reporting a slump in revenues and profits. Full-year 2020 revenue fell 11.2% Y/Y to $4.6 billion, and operating profit dr...

4 months ago - Benzinga

Smith & Nephew PLC (LON:SN) saw its shares slide in early deals as it caught the market on the hop with a disappointing set of results. Shares in the wound care and knee & hip implants specialist were d...

4 months ago - Proactive Investors

Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.

4 months ago - Zacks Investment Research

LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative Pressure...

4 months ago - PRNewsWire

The rally in 2020 may mean many stocks are not cheap any more, but long-term investors can still find robust stocks to buy in a bull market The post 7 Stocks to Buy for a Continued Run with the Market B...

Other stocks mentioned: ATVI, BFOR, BLCN, ROKU, TWTR, UNH
5 months ago - InvestorPlace

Let's see if Smith & Nephew plc (SNN) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

6 months ago - Zacks Investment Research

Smith & Nephew has a solid, growing business which will grow with market growth as well as by acquisition. It has a decent dividend payment history.

7 months ago - Seeking Alpha

These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election. The post 7 Healthcare Stocks That Can Survive Massive Reform appea...

Other stocks mentioned: BMY, CVS, ISRG, MDRX, XPH, TDOC
7 months ago - InvestorPlace

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

In an announcement on Thursday, Smith & Nephew plc (LON: SN) said its underlying revenue is expected to see a 4% decline in the fiscal third quarter. Underlying revenue does not account for non-recurrin...

8 months ago - Invezz

Smith & Nephew SNN, +2.16% SN, -0.91% said it's buying the extremity orthopedics unit of Integra LifeSciences IART, -0.40% ...

Other stocks mentioned: IART
8 months ago - Market Watch

LONDON, Sept. 2, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its NOVOSTITCH PRO Meniscal Repair System in Europe after suc...

9 months ago - PRNewsWire

With the help of the care management platform, Smith+Nephew (SNN) aims to help clinicians reduce the patient's post-acute recovery time.

9 months ago - Zacks Investment Research

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.

Other stocks mentioned: SYK, ZBH
11 months ago - The Motley Fool

Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.

Other stocks mentioned: BDX, F, FCAU, GM, JNJ, MDT, NUVA ...
1 year ago - The Motley Fool

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

The JOURNEY II UK development is expected to provide a major impetus to Smith & Nephew's (SNN) Orthopedics segment.

1 year ago - Zacks Investment Research

Smith & Nephew's (SNN) announces positive study outcomes for REGENETEN.

1 year ago - Zacks Investment Research

Its chief executive's sudden exit sent the stock reeling.

1 year ago - The Motley Fool

Smith & Nephew PLC (SNN) Management on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Smith+Nephew Plc Chief Executive Namal Nawana is stepping down after just 17 months in the role after becoming dissatisfied with his salary at the medical device maker.

1 year ago - Reuters

This can be considered a major step in Smith & Nephew's (SNN) commitment toward strengthening its Global Sports Medicine and ENT segment.

1 year ago - Zacks Investment Research

Smith & Nephew (SNN) has been gaining from several positive developments of late.

1 year ago - Zacks Investment Research

Smith & Nephew PLC (SNN) CEO Namal Nawana on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.

1 year ago - Zacks Investment Research

The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.

2 years ago - Zacks Investment Research

Smith & Nephew PLC (SNN) CEO Namal Nawana on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Smith & Nephew has been gaining investor confidence on consistently positive results.

2 years ago - Zacks Investment Research

On March 12, 2019, Osiris Therapeutics disclosed that Smith & Nephew agreed to acquire the company for $660 million.

Other stocks mentioned: OSIR
2 years ago - Seeking Alpha

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform m... [Read more...]

Industry
Medical Devices
IPO Date
Nov 16, 1999
CEO
Roland Diggelmann
Employees
17,914
Stock Exchange
NYSE
Ticker Symbol
SNN
Full Company Profile

Financial Performance

In 2020, Smith & Nephew's revenue was $4.56 billion, a decrease of -11.25% compared to the previous year's $5.14 billion. Earnings were $448.00 million, a decrease of -25.33%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Smith & Nephew stock is "Buy." The 12-month stock price forecast is 50.17, which is an increase of 16.00% from the latest price.

Price Target
$50.17
(16.00% upside)
Analyst Consensus: Buy